Information displayed below is a subset of the entire knowledge base and may be incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.

Description

The clinical test for indirect bilirubin is a laboratory test that measures the amount of unconjugated bilirubin in a patient's serum. The test is used to diagnose and monitor liver and gallbladder diseases, as well as to evaluate the effectiveness of treatments.

The method for obtaining indirect bilirubin from a patient's serum involves collecting a sample of the patient's blood and then separating the serum from the red blood cells. The serum is then tested for the presence of unconjugated bilirubin. This is done by adding a reagent to the serum, which reacts with the bilirubin to produce a color change. The intensity of the color change is then measured and compared to a standard to determine the amount of unconjugated bilirubin present in the serum.

Synonyms

• Ibili
• unconjugated bilirubin

Other Sample Sources for This Test

• plasma
• umbilical cord blood

Some Diseases Associated with an Abnormal Indirect Bilirubin

• heart valve disorder
• infectious mononucleosis
• Gilbert syndrome
• chronic liver disease
• influenza
• acute pancreatitis
• pneumonia
• congestive heart failure
• bacterial pneumonia
• iron deficiency anemia
• nonmedicinal toxicity
• heat stroke
• drug side effect
• chronic-renal-failure anemia

Detailed Laboratory Testing Information (use the custom search buttons below to find details on these topics)

All of the following must be considered when interpreting clinical findings and are too extensive to be covered on this site: